ZBiotics is the world's first maker of genetically engineered probiotics, purpose-built to improve our health, starting with helping our bodies handle the unique and newly arising biological challenges of modern living. Developed by CEO and co-founder Zack Abbott, Ph.D., the company's flagship product breaks down acetaldehyde, an unwanted byproduct of alcohol associated with the day-after effects of drinking. ZBiotics makes products for consumers who want to live healthier lives and take a more active role in their well-being. A bioengineering company, ZBiotics employs the power of engineered probiotics to bring new functionality to the human body or to augment existing functions. It's a new kind of genetic engineering: transparent, responsible, and built directly for consumers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/27/24 | $12,000,000 | Series A |
Access Capital Goat Rodeo Capital Seamless Seaside Ventures Spring Tide Capital  | undisclosed |
